Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

2 weeks ago 11
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Related

Healthcare Realty Q1 2025 slides: Stable operations despite earnings miss

Healthcare Realty Q1 2025 slides: Stable operations despite ...

2 hours ago 0
Great Elm Group, Inc. Schedules Fiscal 2025 Third Quarter Conference Call and Webcast

Great Elm Group, Inc. Schedules Fiscal 2025 Third Quarter Co...

2 hours ago 1
GFG Closes Oversubscribed Financing

GFG Closes Oversubscribed Financing

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. guadalajara - américa
2. austin weather
3. waco weather
4. john skipper
5. ross dwelley
6. ashli babbitt
7. mlb the show 25
8. fort lauderdale air show
9. fred kerley
10. tuomas iisalo

Popular

Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

3 weeks ago 95
What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

3 weeks ago 94
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 80
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

2 weeks ago 76
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 74
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved